日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PLS-α-GalCer: a novel targeted glycolipid therapy for solid tumors.

PLS-α-GalCer:一种用于治疗实体瘤的新型靶向糖脂疗法

Burks Julian, Tiwary Shweta, Stevens David M, Skoczen Sarah L, Kularatne Ruvanthi N, Stern Stephan T, Berzofsky Jay A

Pelvic Floor Physical Therapy is Self-Reported as a Minimally Effective, and Sometimes Harmful, Treatment for Pudendal Neuralgia: A Cross-Sectional Study

一项横断面研究表明,盆底物理疗法对阴部神经痛的疗效甚微,有时甚至有害。

Niedenfuehr, Jenny M; Stevens, David M; King, Lindsey M

Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine

氯喹和羟氯喹的纳米医学改良

Stevens, David M; Crist, Rachael M; Stern, Stephan T

Choosing between medical management and liver transplant in urea cycle disorders: A conceptual framework for parental treatment decision-making in rare disease

尿素循环障碍的药物治疗与肝移植之争:罕见病家长治疗决策的概念框架

Gerstein, Maya T; Markus, Anne R; Gianattasio, Kan Z; Le Mons, Cynthia; Bartos, Janice; Stevens, David M; Mew, Nicholas Ah

When Is It Important to Measure Unbound Drug in Evaluating Nanomedicine Pharmacokinetics?

在评估纳米药物药代动力学时,何时需要测量游离药物?

Stern, Stephan T; Martinez, Marilyn N; Stevens, David M

Nanosponge formation from organocatalytically-synthesized poly(carbonate) copoplymers

利用有机催化合成的聚碳酸酯共聚物形成纳米海绵

Stevens, David M; Tempelaar, Sarah; Dove, Andrew P; Harth, Eva

Synovial fibroblasts promote the expression and granule accumulation of tryptase via interleukin-33 and its receptor ST-2 (IL1RL1)

滑膜成纤维细胞通过白细胞介素-33及其受体ST-2(IL1RL1)促进类胰蛋白酶的表达和颗粒积累

Shinjiro Kaieda, Kichul Shin, Peter A Nigrovic, Kenjiro Seki, Richard T Lee, Richard L Stevens, David M Lee

Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain

在缺乏白细胞介素 13 受体 α1 链的小鼠中发现 II 型白细胞介素 4 受体的独特功能

Thirumalai R Ramalingam, John T Pesce, Faruk Sheikh, Allen W Cheever, Margaret M Mentink-Kane, Mark S Wilson, Sean Stevens, David M Valenzuela, Andrew J Murphy, George D Yancopoulos, Joseph F Urban Jr, Raymond P Donnelly, Thomas A Wynn